SAN DIEGO--(BUSINESS WIRE)--CB Therapeutics is an innovative biotechnology company focused on the production of high value molecules, compounds and rare ingredients from simple sugars, utilizing yeast and the process of fermentation. Just four months ago, the company moved into a new R&D and production facility in San Diego County, California. It has already achieved a significant production scale up milestone to pilot level production bioreactors at hundreds of liters. This development allows for the further testing of the CB Therapeutics production process in much larger commercial bioreactors.
“We are excited to announce that we have successfully achieved the titers we projected in our largest pilot level production bioreactor,” said Chief Scientific Officer Jacob Vogan. “We are ahead of schedule for our scale-up progress and have made further significant advancements in the scientific platform for fermentation-based cellular agriculture.” Sher Butt, the president and CEO of CB Therapeutics, added: “This key production milestone further de-risks our enterprise and is the last step towards large commercial scale production and customer delivery of a number of high value molecules by the fourth quarter of 2019. We look forward to the further development of our core science and achieving expected economies of scale for our production platform.”
About CB Therapeutics
CB Therapeutics produces high value molecules, compounds and rare ingredients from simple sugars utilizing yeast and the process of fermentation. CB Therapeutics’ expertise in synthetic genomics and bio-engineering has significantly advanced its proprietary production platform of yeasts, enzymes and production processes. After four years of research and development, the CB Therapeutics team is able to produce a broad range of phytochemicals faster, utilizing fewer resources, at greater yields and with more purity, consistency and efficiency than Mother Nature. A 7000+ sf fully-licensed commercial batch facility in San Diego County, California, includes research labs, offices and a production facility for laboratory scale and pilot production runs and is equipped with a suite of bench-top and large-scale fermenters for multiple biosynthetic production applications.